Your browser doesn't support javascript.
loading
SARS-CoV-2 inactivation in laboratory animal tissues with 4% formaldehyde or 5% glutaraldehyde for transfer to biosafety level 1 laboratories.
Pilchová, Veronika; Elmontaser Mergani, Ahmed; Clever, Sabrina; Ciurkiewicz, Malgorzata; Becker, Kathrin; Gerhauser, Ingo; Baumgärtner, Wolfgang; Volz, Asisa; von Köckritz-Blickwede, Maren; Schulz, Claudia.
Afiliação
  • Pilchová V; University of Veterinary Medicine Hannover, Hannover, Germany.
  • Elmontaser Mergani A; University of Veterinary Medicine Hannover, Hannover, Germany.
  • Clever S; University of Veterinary Medicine Hannover, Hannover, Germany.
  • Ciurkiewicz M; University of Veterinary Medicine Hannover, Hannover, Germany.
  • Becker K; University of Veterinary Medicine Hannover, Hannover, Germany.
  • Gerhauser I; University of Veterinary Medicine Hannover, Hannover, Germany.
  • Baumgärtner W; University of Veterinary Medicine Hannover, Hannover, Germany.
  • Volz A; University of Veterinary Medicine Hannover, Hannover, Germany.
  • von Köckritz-Blickwede M; University of Veterinary Medicine Hannover, Hannover, Germany.
  • Schulz C; University of Veterinary Medicine Hannover, Hannover, Germany.
Vet Pathol ; 61(2): 201-206, 2024 Mar.
Article em En | MEDLINE | ID: mdl-37698272
ABSTRACT
The SARS-CoV-2 pandemic required the immediate need to transfer inactivated tissue from biosafety level (BSL)-3 to BSL-1 areas to enable downstream analytical methods. No validated SARS-CoV-2 inactivation protocols were available for either formaldehyde (FA)-fixed or glutaraldehyde (GA)-fixed tissues. Therefore, representative tissue from ferrets and hamsters was spiked with 2.2 × 106 tissue culture infectious dose 50% per ml (TCID50/ml) SARS-CoV-2 or were obtained from mice experimentally infected with SARS-CoV-2. SARS-CoV-2 inactivation was demonstrated with 4% FA or 5% GA at room temperature for 72 hours by a titer reduction of up to 103.8 TCID50/ml in different animal tissues with a maximum protein content of 100 µg/mg and a thickness of up to 10 mm for FA and 8 mm for GA. Our protocols can be easily adapted for validating the inactivation of other pathogens to allow for the transfer of biological samples from BSL-3 areas to BSL-1 laboratories.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: COVID-19 Limite: Animals Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: COVID-19 Limite: Animals Idioma: En Ano de publicação: 2024 Tipo de documento: Article